Monday June 17, 6:00 am ETPress
Release SOURCE:
DISPENSING SOLUTIONS INC.
Dispensing Solutions Appoints New Senior Vice President Of Product Development
SANTA ANA, CA -- Jun 17, 2002 -- Dispensing Solutions, Inc. (DSI), a pharmaceutical
services and management company, today announced the appointment
of Debbie K. Thompson as senior vice president of product
development. In her new position Thompson will be responsible for overall
product direction, including interfacing with product co-ordination
with DSI's marketing and sales departments in the healthcare
marketplace. She will assume responsibility for building
strategic alliances that will provide significant leverage
for DSI's product development, sales, marketing, and professional
services efforts. Thompson will also cultivate DSI's partnering
strategies and maintain existing relationships while developing
new alliances in the U.S. "Deb is the perfect complement to our continued commitment
to providing the highest quality of pharmaceutical products
and services to the healthcare industry," stated Richard
Wolpow, COO. "She brings the leadership and entrepreneurial
skills necessary for DSI to significantly increase our share
in this market. Deb's extensive industry knowledge, proven
track record and experience in the pharmaceutical and healthcare
industries make her an extremely valued addition to our
management team." Thompson brings more than 22 years management experience
in prescription medication management, business/product
development, marketing and administration. Most recently,
Ms. Thompson was the Director of Private Label Sales for
Express Scripts. During her tenure at Express Scripts, Ms.
Thompson was responsible for directing and managing this
newly created department. She focused on developing strategic
partnerships and consultative programs within the PBM, pharmaceutical
manufacture and pharmacy community. Prior to Express Scripts,
Ms. Thompson held various senior level positions. Previously
she was vice president of product management with ValueRx
(acquired by Express Scripts in 1999) and vice president
of client administration for Diagnostek-Perform Cost Management. Dispensing Solutions, Inc., an FDA/DEA registered drug manufacturer
that operates a state-of-the-art Pharmaceutical Repackaging
Facility, offers a full array of Pharmaceutical Management
Services and Products (PMSP). DSI creates custom programs
addressing the prescribing, tracking and dispensing needs
of virtually every type of medical professional, health
care organization, health insurer and/or pharmacy. DSI,
when creating specific programs, addresses several main
objectives: to reduce pharmacy errors and costs, increase
accountability, patient compliance and clinical outcomes.
DSI is one of the few US Repackagers that has the capability
to safely handle the packaging of antibiotic products. Unique
to the industry, DSI has two specifically designed negative-airflow
packaging rooms distinctively for producing Penicillin and
Cephlosporin based products. DSI can also accommodate controlled
substances: Schedule III, IV and V. This is all part of
the company's commitment to supply the purest and safest
products available. Adhering to the most stringent Current
Good Manufacturing Practices (cGMPs), DSI's facility has
nine different production rooms with the ability to accommodate
production runs as small as 500 units up to well over five
million. DSI is located at 3000 West Warner Avenue, Santa Ana, CA
92704;
Phone: 714.437.0330, fax: 714. 437.0336, email: info@dis-sol-inc.com
website: www.dispensingsolutionsinc.com.
|